| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ADAMAS PHARMACEUTICALS INC | 2,601,351 | 43,963,000 | 9.03% | ||
| 2 | Foamix Pharmaceuticals Ltd. | 3,000,000 | 33,300,000 | 6.84% | ||
| 3 | VANDA PHARMACEUTICALS INC COM | 2,010,000 | 32,060,000 | 6.59% | ||
| 4 | SYNERGY PHARMACEUTICALS DEL COM NEW | 4,973,509 | 30,289,000 | 6.22% | ||
| 5 | ZOGENIX INC | 2,440,959 | 29,658,000 | 6.09% | ||
| 6 | NEUROCRINE BIOSCIE COM USD0.001 | 750,000 | 29,025,000 | 5.96% | ||
| 7 | ENANTA PHARMACEUTICALS INC COM | 828,253 | 27,746,000 | 5.70% | ||
| 8 | MEDICINES CO | 750,000 | 25,455,000 | 5.23% | Put | |
| 9 | IGNYTA INC COM | 4,000,000 | 21,200,000 | 4.36% | ||
| 10 | SANOFI SPOND FUNSPONSORED ADR | 5,000,000 | 20,400,000 | 4.19% | ||
| 11 | AVEXIS INC COM | 413,179 | 19,721,000 | 4.05% | ||
| 12 | SAGE THERAPEUTICS | 385,683 | 19,693,000 | 4.05% | ||
| 13 | THERAPEUTICSMD INC | 3,276,010 | 18,903,000 | 3.88% | ||
| 14 | TREVENA INC | 3,000,650 | 17,644,000 | 3.62% | ||
| 15 | COLUCID PHARMACEUTICALS INC COM | 437,865 | 15,938,000 | 3.27% | ||
| 16 | GLOBAL BLOOD THERAPEUTICS IN COM | 1,000,000 | 14,450,000 | 2.97% | ||
| 17 | DBV TECHNOLOGIES | 370,000 | 12,998,000 | 2.67% | ||
| 18 | Bovie Medical Corp | 3,055,000 | 10,967,000 | 2.25% | ||
| 19 | INOTEK PHARMACEUTICALS CORP | 1,500,000 | 9,150,000 | 1.88% | ||
| 20 | ACADIA PHARMACEUTICALS INC COM | 270,000 | 7,787,000 | 1.60% | ||
| 21 | CONNECTURE INC COM | 4,127,232 | 6,934,000 | 1.42% | ||
| 22 | Sunesis Pharmaceuticals, Inc. | 1,537,873 | 5,567,000 | 1.14% | ||
| 23 | BIOCRYST PHARMACEUTICALS | 725,000 | 4,589,000 | 0.94% | Put | |
| 24 | MYOVANT SCIENCES LTD | 350,000 | 4,354,000 | 0.89% | ||
| 25 | MIRATI THERAPEUTICS INC COM | 870,261 | 4,134,000 | 0.85% | ||
| 26 | OCERA THERAPEUTICS INC | 1,963,777 | 4,124,000 | 0.85% | ||
| 27 | DERMIRA INC | 114,080 | 3,460,000 | 0.71% | ||
| 28 | BIOCRYST PHARMACEUTICALS | 500,000 | 3,165,000 | 0.65% | Call | |
| 29 | ALIMERA SCIENCES INC | 2,293,675 | 2,477,000 | 0.51% | ||
| 30 | TENAX THERAPEUTICS INC COM | 1,108,593 | 2,162,000 | 0.44% | ||
| 31 | Catabasis Pharmaceuticals Inc | 556,537 | 2,009,000 | 0.41% | ||
| 32 | ALNYLAM PHARMACEUTICALS INC | 51,935 | 1,944,000 | 0.40% | ||
| 33 | ARADIGM CORP COM | 791,870 | 1,267,000 | 0.26% | ||
| 34 | STREAMLINE HEALTH SOLUTIONS COM | 151,611 | 190,000 | 0.04% | ||
| 35 | OPHTHOTECH CORP COM | 7,100 | 34,000 | 0.01% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000930413-17-000546, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
